Molecular Characterization of <i>TSC1</i> and <i>TSC2</i> Variants in a Greek Cohort of Tuberous Sclerosis Complex Patients. [PDF]
Avgeris SN +8 more
europepmc +1 more source
mTORC1 activation induces B7-H3-dependent metabolic reprogramming in renal cell carcinoma (RCC). [PDF]
Li K +9 more
europepmc +1 more source
Kidney Cyst Epithelia in Tuberous Sclerosis Complex (TSC) Exhibit Propagation and Expansion of A-Intercalated, but Loss of B-Intercalated and Principal Cells: The Role of FOXI1, FOXP1, and DMRT2 Transcription Factors. [PDF]
Soleimani M +4 more
europepmc +1 more source
TSC2 methylation is required for its stabilization
Yuji Yamamoto, Tsukasa Suzuki, Jun Inoue
openaire +2 more sources
Case Report: Acquired CDKN2A/B deletion and mTOR inhibitor resistance in TSC2-mutant metastatic epithelioid angiomyolipoma. [PDF]
He S +9 more
europepmc +1 more source
Translational dysregulation as a mechanistic driver of cognitive, behavioral, and affective phenotypes in FXS and TSC. [PDF]
Lawal S, Mujtaba M, Shrestha P.
europepmc +1 more source
Correlations between TSC Expression and Menorrhagia in Adenomyosis Patients. [PDF]
Gu NH +10 more
europepmc +1 more source
ENT1 inhibitor J4 restores cognitive function and white-matter integrity in a mouse model of tuberous sclerosis complex. [PDF]
Hsieh CC +10 more
europepmc +1 more source
A novel synonymous TSC2 mutation in a Chinese family leads to tuberous sclerosis type 2 by disrupting Normal pre-mRNA splicing. [PDF]
Zhang C, Li S, Leng R, Deng M, Yang G.
europepmc +1 more source
Sea-blue histiocytosis and thrombocytopenia successfully treated with an mTORC1 inhibitor: a case report. [PDF]
Li H +7 more
europepmc +1 more source

